Log in to save to my catalogue

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-...

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_302627

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC) : patient-reported quality-of-life outcomes of a randomised, controlled, 3 trial

About this item

Full title

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC) : patient-reported quality-of-life outcomes of a randomised, controlled, 3 trial

Journal title

The lancet oncology, 2021, Vol.22 (2), p.235

Language

English

Formats

More information

Scope and Contents

Contents

Background The HYPO-RT-PC trial compared conventionally fractionated radiotherapy with ultra-hypofractionated radiotherapy in patients with localised prostate cancer. Ultra-hypofractionation was non-inferior to conventional fractionation regarding 5-year failure-free survival and toxicity. We aimed to assess whether patient-reported quality of life...

Alternative Titles

Full title

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC) : patient-reported quality-of-life outcomes of a randomised, controlled, 3 trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_gup_ub_gu_se_302627

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_302627

Other Identifiers

ISSN

1474-5488,1470-2045

DOI

10.1016/S1470-2045(20)30581-7

How to access this item